Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the company will participate in the 20th Annual Needham Virtual Healthcare Conference, a fully virtual management access conference, taking place April 12-15. President and Chief Executive Officer, Mark Foley, is scheduled to participate in a fireside chat on Tuesday, Ap
April 6, 2021
· 2 min read